Live Oak Health Sciences Fund LOGSX Fund Analysis

| Medalist Rating as of | See Oak Associates Investment Hub

Morningstar’s Analysis LOGSX

Will LOGSX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Live Oak Health Sciences holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center